IN SITU-FORMING GELS FOR OPHTHALMIC DRUG-DELIVERY

被引:90
作者
KUMAR, S [1 ]
HAGLUND, BO [1 ]
HIMMELSTEIN, KJ [1 ]
机构
[1] UNIV NEBRASKA,MED CTR,DEPT PHARMACEUT SCI,OMAHA,NE 68198
来源
JOURNAL OF OCULAR PHARMACOLOGY | 1994年 / 10卷 / 01期
关键词
D O I
10.1089/jop.1994.10.47
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Poor bioavailability of ophthalmic solutions caused by dilution and drainage from the eye can be overcome by using in situ-forming ophthalmic drug delivery systems prepared from polymers that exhibit reversible phase transitions. Joshi et al. (1), have demonstrated that aqueous compositions that reversibly gel in response to simultaneous variations in at least two physical parameters, such as temperature, pH, and ionic strength, can be formed by appropriate combinations of macromolecular polymers which exhibit reversible gelation properties. In the present study, the theological characterization of such a system, prepared by a combination of Carbopol (R) (C) and methyl cellulose (MC), was carried out at two different pH (4.0 and 7.4) and temperatures (25 and 37 degrees C) by rotational cone and plate viscometry. The shear stress (tau) vs, shear rate (D) flow curves of the aqueous polymer solutions indicated a pseudoplastic behavior, with a yield point. An increase in pH from 4.0 to 7.4, or temperature from 25 to 37 degrees C, resulted in an increase in viscosity (eta), tau, and yield point, the magnitude of changes being highest when both the parameters were altered simultaneously. An increase in concentration of either C or MC, or an increase in MC molecular weight results in an increase in eta, tau, and yield point. Among the compositions studied, a solution containing 1.5% MC 0.3% C was found to have low eta, and formed a strong gel under simulated physiological conditions. Such a system can be formulated as drug containing liquid suitable for administration by instillation into the eye, which upon exposure to physiological conditions will shift to the gel (semi-solid) phase, thus increasing the precorneal residence time of the delivery system and enhancing ocular bioavailability.
引用
收藏
页码:47 / 56
页数:10
相关论文
共 16 条
[1]  
Joshi A., Ding S., Himmelstein K.J.
[2]  
Sieg J.W., Robinson J.R., Mechanistic studies of transcorneal permeation of pilocarpine, J. Pharm. Sci., 65, 12, pp. 1816-1822, (1976)
[3]  
Lee V.H.L., Precorneal, corneal, and postcorneal factors, pp. 59-81, (1993)
[4]  
Chein Y.W., Cabana B.E., Mares S.E., Ocular controlled-release drug administration, pp. 13-50
[5]  
Schoenwald R.D., Smolen V.F., Drug-absorption analysis from pharmacological Data II: Transcorneal biophasic availability of tropicamide, J. Pharm. Sci., 60, pp. 1039-1045, (1971)
[6]  
Lee V.H.L., Robinson J.R., Review: Topical ocular drug delivery: Recent developments and future challenges, J. Ocular Pharmacol., 2, pp. 67-108, (1986)
[7]  
Lee V.H.L., Review: New directions in the optimization of ocular drug delivery, J. Ocular Pharmacol., 6, pp. 157-164, (1990)
[8]  
Miller S.C., Donovan M.D., Effect of poloxomer 407 gel on the mitotic activity of pilocarpine nitrate in rabbits, Int. J. Pharm, 12, pp. 147-152, (1982)
[9]  
Vadnere M., Amidon G., Lindenbaum S., Haslam J.L., Thermodynamic studies on the gel-sol transition of some pluronic polyols, Int. J. Pharm., 22, pp. 207-218, (1984)
[10]  
Haslam J.L., Higuchi T., Mlodozeniec A.R., Drug delivery system utilizing thermosetting gels, (1984)